Capricor Therapeutics Inc
NASDAQ:CAPR
Intrinsic Value
The intrinsic value of one
CAPR
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 24.17 USD,
Capricor Therapeutics Inc
is
hidden
.
Valuation History
Capricor Therapeutics Inc
CAPR looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CAPR usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Capricor Therapeutics Inc.
Fundamental Analysis
CAPR Profitability Score
Profitability Due Diligence
Score
CAPR Solvency Score
Solvency Due Diligence
Score
Revenue & Expenses Breakdown
Capricor Therapeutics Inc
Balance Sheet Decomposition
Capricor Therapeutics Inc
Capricor Therapeutics Inc
Free Cash Flow Analysis
Capricor Therapeutics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Capricor Therapeutics Inc
Wall St
Price Targets
CAPR Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CAPR
is 51.82 USD
with a low forecast of 41.41 USD and a high forecast of 65.1 USD.
Dividends
Current shareholder yield for
CAPR is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CAPR
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 24.17 USD,
Capricor Therapeutics Inc
is
hidden
.